Literature DB >> 8241838

Platelet activation in coronary artery disease.

M R Cahill1, A C Newland.   

Abstract

The role of platelets in coronary artery disease has become increasingly apparent in the last decade. Platelets are the main components of arterial thrombi, and they also contribute to the development of atheroma and smooth muscle hypertrophy in arterial walls. Platelets are known to circulate as round, inactive spheres which undergo a succession of changes before they become functional. These changes result in activated platelets. Platelet activation has been demonstrated during acute coronary events. There is increasing evidence that an increased proportion of platelets circulate in an activated form in patients with coronary artery disease and also in other disease states in which thrombosis is a feature. In this review we examine some of the evidence for these statements.

Entities:  

Mesh:

Year:  1993        PMID: 8241838

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  4 in total

1.  Effects of various doses of aspirin on platelet activity and endothelial function.

Authors:  Takashi Furuno; Fumiyasu Yamasaki; Takeshi Yokoyama; Kyoko Sato; Takayuki Sato; Yoshinori Doi; Tetsuro Sugiura
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

2.  Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome.

Authors:  Alicja Kasperska-Zajac; Marek Nowakowski; Barbara Rogala
Journal:  Inflammation       Date:  2004-10       Impact factor: 4.092

3.  Modulation of P-selection and platelet aggregation in chronic periodontitis: A clinical study.

Authors:  Ramesh Perumal; Maheashwari Rajendran; Malathi Krishnamurthy; Kiran Kumar Ganji; Sunil Dattuji Pendor
Journal:  J Indian Soc Periodontol       Date:  2014-05

4.  Antiplatelet and antithrombotic effects of cordycepin-enriched WIB-801CE from Cordyceps militaris ex vivo, in vivo, and in vitro.

Authors:  Hyuk-Woo Kwon; Jung-Hae Shin; Deok Hwi Lim; Woo Jeong Ok; Gi Suk Nam; Min Ji Kim; Ho-Kyun Kwon; Jun-Hee Noh; Je-Young Lee; Hyun-Hong Kim; Jong-Lae Kim; Hwa-Jin Park
Journal:  BMC Complement Altern Med       Date:  2016-12-07       Impact factor: 3.659

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.